Former NimbleGen CEO to Head Sangamo Bio, Spotfire Hires Tony Colangelo and Olle Landstrom, ABI s Deborah Smeltzer Lands at Dynavax, Guava Hires BD s Philip Vorwald, and Others | GenomeWeb

Nick Colangelo has become senior vice president of corporate development and operations at Oscient Pharmaceuticals, the Waltham, Mass.-based company said yesterday. He comes to Oscient from Eli Lilly, where he was a managing director of Lilly Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.